Table 5.
Progression data at 2-years of follow-up in the study groups
| Site of reccurence / progression | Combined organ-sparing management | Radical nephroureterectomy | Statistical evaluation |
|---|---|---|---|
| Upper tract reccurence | 3 (9%) | – | χ2 = 1.65; р = 0.79 |
| Bladder reccurence | 3 (9%) | 5 (15%) | |
| Nodal metastases | 4 (12%) | 5 (15%) | |
| Distant metastases | 3 (9%) | 4 (12%) | |
| UTUC-associated death | 3 (9%) | 4 (12%) |
UTUC – upper tract urothelial cancer